Selecta Biosciences, Inc.
SELB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $17,337 | $103,505 | $103,505 |
| - Cash | $143,384 | $160,324 | $180,434 | $212,610 |
| + Debt | $8,727 | $13,349 | $14,066 | $13,984 |
| Enterprise Value | – | -$129,638 | -$62,863 | -$95,121 |
| Revenue | $452 | $298 | $1,100 | $21,175 |
| % Growth | 51.7% | -72.9% | -94.8% | – |
| Gross Profit | $0 | $0 | $0 | $18,668 |
| % Margin | 0% | 0% | 0% | 88.2% |
| EBITDA | -$35,296 | -$21,811 | $0 | -$40,126 |
| % Margin | -7,808.8% | -7,319.1% | 0% | -189.5% |
| Net Income | -$35,902 | $15,886 | -$17,710 | -$31,282 |
| % Margin | -7,942.9% | 5,330.9% | -1,610% | -147.7% |
| EPS Diluted | -1.38 | 0.5 | -0.11 | -0.2 |
| % Growth | -376% | 554.5% | 45% | – |
| Operating Cash Flow | -$15,600 | -$17,521 | -$23,108 | $4,201 |
| Capital Expenditures | -$1,292 | -$2,595 | -$1,075 | -$8,951 |
| Free Cash Flow | -$16,892 | -$20,116 | -$24,183 | -$4,750 |